Implications of reversibility testing on prevalence and risk factors for chronic obstructive pulmonary disease: A community study

Thorax

Volumn 60, Issue 10, 2005, Pages 842-847

  Johannessen, A ^a   Omenaas, E R ^a,b   Bakke, P S ^a,b   Gulsvik, A ^a,b  

^a UNIVERSITY OF BERGEN   (Norway)

^b HAUKELAND UNIVERSITY HOSPITAL   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

SALBUTAMOL;

ADULT; AGED; ARTICLE; BODY MASS; BRONCHODILATATION; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; EDUCATION; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; MAJOR CLINICAL STUDY; MALE; POPULATION RESEARCH; PREDICTION; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR; SEX DIFFERENCE; SMOKING; SPIROMETRY;

ADULT; AGED; AGED, 80 AND OVER; BRONCHODILATOR AGENTS; FEMALE; FORCED EXPIRATORY VOLUME; HUMANS; MALE; MIDDLE AGED; NORWAY; ODDS RATIO; PREVALENCE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RISK FACTORS; VITAL CAPACITY;

EID: 26944434810     PISSN: 00406376     EISSN: None     Source Type: Journal    
DOI: 10.1136/thx.2005.043943     Document Type: Article

References (32)

1. Pauwels RA, Buist AS, Calverley PM, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) workshop summary. Am J Respir Crit Care Med 2001;163:1256-76.
2. Fabbri LM, Hurd SS. Global strategy for the diagnosis, management and prevention of COPD: 2003 update. Eur Respir J 2003;22:1-2.
3. Celli BR, MacNee W. Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper. Eur Respir J 2004;23:932-46.
4. 1. Eur Respir J 2004;23:497-8.
5. de Marco R, Accordini S, Cerveri I, et al. An international survey of chronic obstructive pulmonary disease in young adults according to GOLD stages. Thorax 2004;59:120-5.
6. Vestbo J, Lange P. Can GOLD Stage 0 provide information of prognostic value in chronic obstructive pulmonary disease? Am J Respir Crit Care Med 2002;166:329-32.
7. Hardie JA, Buist AS, Vollmer WM, et al. Risk of over-diagnosis of COPD in asymptomatic elderly never-smokers. Eur Respir J 2002;20:1117-22.
8. Celli BR, Halbert RJ, Isonaka S, et al. Population impact of different definitions of airway obstruction. Eur Respir J 2003;22:268-73.
9. Mannino DM, Buist AS, Petty TL, et al. Lung function and mortality in the United States: data from the First National Health and Nutrition Examination Survey follow up study. Thorax 2003;58:388-93.
10. Calverley PM. The GOLD classification has advanced understanding of COPD. Am J Respir Crit Care Med 2004;170:211-4.
11. Eagan TM, Gulsvik A, Eide GE, et al. Occupational airborne exposure and the incidence of respiratory symptoms and asthma. Am J Respir Crit Care Med 2002;166:933-8.
12. Bakke PS, Hanoa R, Gulsvik A. Educational level and obstructive lung disease given smoking habits and occupational airborne exposure: a Norwegian community study. Am J Epidemiol 1995;141:1080-8.
13. Nelson SB, Gardner RM, Crapo RO, et al. Performance evaluation of contemporary spirometers. Chest 1990;97:288-97.
14. Bakke P, Baste V, Hanoa R, et al. Prevalence of obstructive lung disease in a general population: relationship to occupational title and exposure to some airborne agents. Thorax 1991;46:863-70.
15. American Thoracic Society. Standardization of spirometry, 1994 update. Am J Respir Crit Care Med 1995;152:1107-36.
16. Gulsvik A, Tosteson T, Bakke P, et al. Expiratory and inspiratory forced vital capacity and one-second forced volume in asymptomatic never-smokers in Norway. Clin Physiol 2001;21:648-60.
17. StataCorp. Stata Statistical Software: Release 8.0. College Station, TX: Stata Corporation, 2003.
18. SPSS Inc. SPSS Base 12.0 user's guide. Chicago, IL: Prentice Hall, 2003.
19. Greenland S, Drescher K. Maximum likelihood estimation of the attributable fraction from logistic models. Biometrics 1993;49:865-72.
20. Eagan TM, Eide GE, Gulsvik A, et al. Nonresponse in a community cohort study: predictors and consequences for exposure-disease associations. J Clin Epidemiol 2002;55:775-81.
21. Bakke P, Gulsvik A, Lilleng P, et al. Postal survey on airborne occupational exposure and respiratory disorders in Norway: causes and consequences of non-response. J Epidemiol Community Health 1990;44:316-20.
22. Global Initiative for Chronic Obstructive Lung Disease. Executive summary update, 2004. Available at http://www.goldcopd.com.
23. Kommann O, Beeh KM, Beier J, et al. Newly diagnosed chronic obstructive pulmonary disease. Clinical features and distribution of the novel stages of the Global Initiative for Obstructive Lung Disease. Respiration 2003;70:67-75.
24. Pena VS, Miravitlles M, Gabriel R, et al. Geographic variations in prevalence and underdiagnosis of COPD: results of the IBERPOC multicentre epidemiological study. Chest 2000;118:981-9.
25. Lundback B, Lindberg A, Lindstrom M, et al. Not 15 but 50% of smokers develop COPD? Report from the Obstructive Lung Disease in Northern Sweden Studies. Respir Med 2003;97:115-22.
26. Anon. Burden of Lung Disease (BOLD) initiative, 2005. Available at http:// www.kpchr.org/boldcopd.
27. Prescott E, Lange P, Vestbo J. Socioeconomic status, lung function and admission to hospital for COPD: results from the Copenhagen City Heart Study. Eur Respir J 1999;13:1109-14.
28. Landbo C, Prescott E, Lange P, et al. Prognostic value of nutritional status in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1999;160:1856-61.
29. Blanc PD, Eisner MD, Trupin L, et al. The association between occupational factors and adverse health outcomes in chronic obstructive pulmonary disease. Occup Environ Med 2004;61:661-7.
30. Johannessen A, Omenaas E, Bakke P, et al. Incidence of GOLD-defined chronic obstructive pulmonary disease in a general adult population. Int J Tuberc Lung Dis 2005;9:926-32.
31. Becklake MR, Kauffmann F. Gender differences in airway behaviour over the human life span. Thorax 1999;54:1119-38.
32. Guerra S, Sherrill DL, Bobadilla A, et al. The relation of body mass index to asthma, chronic bronchitis, and emphysema. Chest 2002;122:1256-63.